# Post-CA Neuroprotection With Magnesium

> **NCT06455514** · PHASE1 · RECRUITING · sponsor: **NYU Langone Health** · enrollment: 178 (estimated)

## Conditions studied

- Cardiac Arrest
- Return of Spontaneous Circulation

## Interventions

- **DRUG:** Magnesium Sulfate
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT06455514
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-25
- **Primary completion:** 2026-03-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 178 (ESTIMATED)
- **Last updated:** 2026-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06455514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06455514, "Post-CA Neuroprotection With Magnesium". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06455514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*